España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Plus Therapeutics
PSTV
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.75
0.01
0.57%
At Close: -
$1.78
0.03
1.71%
After Hours: 7:11 PM EDT
15 minutes delayed
Get Report
Comment
Plus Therapeutics (PSTV) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Plus Therapeutics (NASDAQ:PSTV) Stock
Plus Therapeutics Stock (NASDAQ: PSTV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, June 07, 2024
PLUS THERAPEUTICS Says Greg Fuller Joins Comp...
Benzinga Newsdesk
Wednesday, May 15, 2024
Plus Therapeutics Q1 2024 GAAP EPS $(0.75) Be...
Benzinga Newsdesk
Thursday, May 09, 2024
Plus Therapeutics Has Acquired Assets For The...
Benzinga Newsdesk
Monday, May 06, 2024
Plus Therapeutics shares are trading higher a...
Benzinga Newsdesk
Plus Therapeutics Announced Private Placement...
Benzinga Newsdesk
Monday, April 22, 2024
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
Vandana Singh
Plus Therapeutics Says 'Plus now has $23 mill...
Benzinga Newsdesk
Plus Therapeutics Receives $3M Award Recommen...
Benzinga Newsdesk
Monday, March 25, 2024
Plus Therapeutics Announces Validation & Clin...
Benzinga Newsdesk
Monday, March 11, 2024
Plus Therapeutics Has Completed Dosing In Coh...
Benzinga Newsdesk
Tuesday, March 05, 2024
Recap: Plus Therapeutics Q4 Earnings
Benzinga Insights
Plus Therapeutics Q4 EPS $(0.70) Beats $(1.07...
Benzinga Newsdesk
Earnings Scheduled For March 5, 2024
Benzinga Insights
Monday, March 04, 2024
Plus Therapeutics Earnings Preview
Benzinga Insights
Monday, December 18, 2023
Plus Therapeutics Says The Award Payment Of $...
Benzinga Newsdesk
Tuesday, December 12, 2023
Plus Therapeutics Partners With K2bio To Deve...
Benzinga Newsdesk
Monday, November 20, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Thursday, November 09, 2023
Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2
Lisa Levin
Friday, November 03, 2023
Plus Therapeutics Says It Has Been Granted U....
Benzinga Newsdesk
Wednesday, November 01, 2023
Why Plus Therapeutics Stock Popped Today
Ryan Gustafson
Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, October 31, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Plus Therapeutics shares are trading higher a...
Benzinga Newsdesk
Plus Therapeutics Announces Share Repurchase ...
Benzinga Newsdesk
Plus Therapeutics Q3 EPS $(1.00) Vs $(2.85) L...
Benzinga Newsdesk
Earnings Scheduled For October 31, 2023
Benzinga Insights
Monday, October 30, 2023
Earnings Outlook For Plus Therapeutics
Benzinga Insights
Monday, October 16, 2023
Why Is Liquid Biopsy Firm Biocept Stock Trading Lower Today?
Vandana Singh
Tuesday, October 10, 2023
Plus Therapeutics Completes Dosing in Cohort ...
Benzinga Newsdesk
Friday, September 29, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Monday, September 18, 2023
Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
Lisa Levin
Monday, September 11, 2023
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Plus Therapeutics Receives $1.9 Million Advan...
Benzinga Newsdesk
Friday, September 08, 2023
Plus Therapeutics shares are trading lower af...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today?
Vandana Singh
EXCLUSIVE: Plus Therapeutics Tells Benzinga '...
Benzinga Newsdesk
EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers
Vandana Singh
EXCLUSIVE: Plus Therapeutics Tells Benzinga C...
Benzinga Newsdesk
Tuesday, September 05, 2023
Plus Therapeutics Initiates Part B Of ReSPECT...
Benzinga Newsdesk
Tuesday, August 15, 2023
HC Wainwright & Co. Reiterates Buy on Plus Th...
Benzinga Newsdesk
Monday, August 14, 2023
Plus Therapeutics Q2 EPS $(0.59) Beats $(1.91...
Benzinga Newsdesk
Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference
Johnny Rice
Earnings Scheduled For August 14, 2023
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Plus Th...
Benzinga Newsdesk
Friday, August 11, 2023
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Plus Therapeutics Earnings Preview
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch